International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 4 , Pages 1128-1133, 15 November 2008

Neoadjuvant Radiation Is Associated With Improved Survival in Patients With Resectable Pancreatic Cancer: An Analysis of Data From the Surveillance, Epidemiology, and End Results (SEER) Registry

  • Alexander M. Stessin, B.S.

      Affiliations

    • Tri-Institutional M.D.–Ph.D. Program, New York, NY
    • Weill Medical College of Cornell University, New York, NY
  • ,
  • Joshua E. Meyer, M.D.

      Affiliations

    • New York Presbyterian Hospital, New York, NY
  • ,
  • David L. Sherr, M.D.

      Affiliations

    • New York Presbyterian Hospital, New York, NY
    • Corresponding Author InformationReprint requests to: David Sherr, M.D., Stich Radiation Oncology Center, Weill Cornell Medical College, 525 East 68th Street, Box 575, New York, NY 10065. Tel: (212) 746-3614; Fax: (212) 746-8749

Received 4 September 2007; received in revised form 25 February 2008; accepted 26 February 2008. published online 05 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Presented at the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), October 29–November 1, 2007, Los Angeles, CA.

 Conflict of interest: none.

PII: S0360-3016(08)00421-5

doi:10.1016/j.ijrobp.2008.02.065

International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 4 , Pages 1128-1133, 15 November 2008